HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myocardial infarction increases ACE2 expression in rat and humans.

AbstractAIMS:
Angiotensin converting enzyme (ACE) 2 catalyses the cleavage of angiotensin (Ang) I to Ang 1-9 and of Ang II to Ang 1-7. ACE2 deficiency impairs cardiac contractility and upregulates hypoxia-induced genes, suggesting a link with myocardial ischaemia. We studied the expression of ACE2 after myocardial infarction (MI) in the rat as well as in human failing hearts.
METHODS AND RESULTS:
Rats were killed at days 1, 3, and 28 after MI, or treated for 4 weeks with the ACE inhibitor ramipril (1 mg/kg). Cardiac gene and protein expression of ACE and ACE2 were assessed by quantitative real-time reverse transcriptase-polymerase chain reaction and immunohistochemistry/activity assays/in vitro autoradiography, respectively. Both ACE (P = 0.022) and ACE2 (P = 0.015) mRNA increased in the border/infarct area compared with the viable area at day 3 after MI. By day 28, increases in ACE (P = 0.005) and ACE2 (P = 0.006) mRNA were also seen in the viable myocardium of MI rats compared with myocardium of control rats. ACE2 protein localized to macrophages, vascular endothelium, smooth muscle, and myocytes. Ramipril attenuated cardiac hypertrophy and inhibited cardiac ACE. In contrast, ramipril had no effect on cardiac ACE2 mRNA, which remained elevated in all areas of the MI rat heart. Immunoreactivity of both ACE and ACE2 increased in failing human hearts.
CONCLUSION:
The increase in ACE2 after MI suggests that it plays an important role in the negative modulation of the renin angiotensin system in the generation and degradation of angiotensin peptides after cardiac injury.
AuthorsLouise M Burrell, John Risvanis, Eiji Kubota, Rachael G Dean, Peter S MacDonald, Sai Lu, Christos Tikellis, Sharon L Grant, Rebecca A Lew, A Ian Smith, Mark E Cooper, Colin I Johnston
JournalEuropean heart journal (Eur Heart J) Vol. 26 Issue 4 Pg. 369-75; discussion 322-4 (Feb 2005) ISSN: 0195-668X [Print] England
PMID15671045 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • RNA, Messenger
  • Carboxypeptidases
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Ace2 protein, rat
  • Angiotensin-Converting Enzyme 2
  • Ramipril
Topics
  • Aged
  • Angiotensin-Converting Enzyme 2
  • Angiotensin-Converting Enzyme Inhibitors (pharmacology)
  • Animals
  • Carboxypeptidases (biosynthesis, genetics)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (enzymology)
  • Myocardium (enzymology)
  • Peptidyl-Dipeptidase A (biosynthesis, genetics)
  • RNA, Messenger (genetics)
  • Ramipril (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Renin-Angiotensin System
  • Reverse Transcriptase Polymerase Chain Reaction (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: